Methamphetamine-Alcohol Interactions and Mechanisms of Augmented Toxicity to Brain and Peripheral Organs
Methamphetamine-Alcohol Interactions and Mechanisms of Augmented Toxicity to Brain and Peripheral Organs
批准号:
9381361
负责人:
Bryan K Yamamoto
金额:
$50.68万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-05-31
关键词:
AMPA ReceptorsAcuteAddictive BehaviorAffectAlcohol abuseAlcohol consumptionAlcoholsAmphetamine AddictionAnti-Inflammatory AgentsAnti-inflammatoryAppearanceAstrocytesAttenuatedBehavioralBiologicalBloodBrainBrain InjuriesCalciumCell surfaceClinicalComorbidityCorpus striatum structureDiagnosisDiseaseDopamineDrug toxicityEpidemiologyExposure toGenetic TranscriptionGlutamatesGoalsITGAM geneIndividualInfiltrationInflammationInflammation MediatorsInflammatoryInflammatory disease of the intestineIntakeInterleukin-1 betaLasersLeadLong-Term EffectsMeasuresMediatingMediator of activation proteinMethamphetamineMicrogliaMicroscopyMissionNational Institute of Drug AbuseNerve DegenerationNervous System TraumaNeurobiologyNeurologic EffectNeuronsOrganOutcomePeripheralPharmaceutical PreparationsPhenotypePredisposing FactorProteinsProteolysisPublic HealthRattusSerotoninSerumSliceSuggestionSumTLR4 geneTNF geneTestingTight JunctionsTissuesToxic effectTranscriptUp-Regulationalcohol use disorderamphetamine usebasebrain cellcell typecytokinedrug of abuseexcitotoxicityfrontal lobegut microbiomemethamphetamine abusemethamphetamine effectmethamphetamine exposuremethamphetamine usemicrobiotamonoaminemonocyteneurobiological mechanismneurochemistryneuroinflammationneuromechanismneurotoxicneurotoxicityneurotransmissionnext generationoccludinresponsesynergismtranscriptometranscriptome sequencingtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Methamphetamine (Meth) and alcohol (EtOH) are widely co-abused but little is known about how they interact
to cause potential harm. Despite the fact that both drugs have similar effects on peripheral organs, these
peripheral effects such as inflammation are typically ignored when evaluating their individual neurobiological
effects. Moreover, Meth and EtOH also share common neurochemical underpinnings such as increased
crosstalk between glutamate neurotransmission and neuroinflammation that would predict additive or supra-
additive neurological effects when the drugs are co-abused. Thus, co-exposure to Meth and EtOH may result
in an exacerbated neurotoxic, excitotoxic, and neuroinflammatory profile. No studies however, have
systematically examined the co-exposure of Meth and EtOH, their peripheral effects, and the contribution of
their combined peripheral effects to an enhanced neurotoxicity. Therefore, the objective of the proposal is to
identify convergent peripheral and central neurobiological mechanisms involving defined brain cell types that
underlie the potential synergistic neurotoxic effects of the co-exposure to Meth and EtOH.
The central hypothesis is that the neurotoxic effects of Meth on dopamine and 5HT terminals and neurons
are augmented and preceded by the peripheral pro-inflammatory effects of voluntary EtOH intake on the gut to
exacerbate neuroinflammation and excitotoxic glutamate neurotransmission. Specific Aim 1 will determine that
inflammation in the gut is associated with voluntary EtOH drinking and will precede and exacerbate the
neurotoxic effects of Meth. Specific Aim 2 will define the brain cell phenotype and changes in its transcriptome
related to inflammatory mediators and glutamate transmission that are affected by EtOH drinking and
subsequent exposure to Meth. The outcomes of Specific Aim 2 will guide and be integrated with Specific Aim
3 that will identify the neural mechanisms, consequences, and neurobiological significance of the co-abuse of
Meth and EtOH by assessing how glutamate neurotransmission and the excitotoxicity of Meth are influenced
by peripheral inflammation from gut. Moreover, transcription changes derived individually from astrocytes,
microglia and neurons identified in Aim 2 in response to peripheral inflammation will be examined for their
effects of glutamate neurotransmission. The long-term goal is to highlight the importance of peripheral factors
in mediating the neurobiological and behavioral effects of drugs of abuse and to develop a feasible
neuroprotective strategy that targets peripheral inflammation and mitigates the harmful biological
consequences associated with the co-abuse of Meth and EtOH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methamphetamine, Stress and Brain Endothelium
-
批准号:8599015
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:8661737
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:9122805
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:9044745
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7795247
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7196550
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7579929
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7664115
-
项目类别:
-
资助金额:$8.8万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7032142
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7367125
-
项目类别:
-
资助金额:$18.26万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6872592
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6694381
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:7070101
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6921502
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6778353
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120087
-
项目类别:
-
资助金额:$21.4万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120086
-
项目类别:
-
资助金额:$13.07万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120088
-
项目类别:
-
资助金额:$20.1万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine Toxicity and Corticostriatal Glutamate
-
批准号:7816726
-
项目类别:
-
资助金额:$47.22万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:6191387
-
项目类别:
-
资助金额:$32.69万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
海外基金